Blueberry-Derived Exosome-Like Nanoparticles Counter the Response to TNF-α-Induced Change on Gene Expression in EA.hy926 Cells.
Level 5 - mechanism / opinion, no new human data
in vitro bench research
PubMed 32397678 · doi:10.3390/biom10050742
What was done
Researchers evaluated the cellular uptake and biological activity of blueberry-derived exosome-like nanoparticles (B-ELNs) in an immortalized human endothelial cell line (EA.hy926). Endothelial cells were pretreated with B-ELNs and challenged with tumor necrosis factor-alpha (TNF-α) to evaluate internalization, reactive oxygen species (ROS) production, cell viability, and differential gene expression.
What was found
EA.hy926 cells internalized B-ELNs in a dose-dependent manner. Pretreatment with B-ELNs countered TNF-α-induced ROS generation and loss of cell viability, and modulated the expression of 29 genes (fold change > 1.5) induced by TNF-α compared to control. Bioinformatic analysis mapped these to 340 canonical pathways, 121 KEGG pathways, and 121 GO Biological processes, identifying candidate targets including PTGIS, MAPK14, and PDE7A. Specific quantitative values for ROS and viability were not reported in the abstract.
Why it matters
This study provides mechanistic evidence that dietary plant-derived exosome-like nanoparticles can be internalized by human endothelial cells and counter inflammatory stress responses, highlighting their potential as therapeutic carriers.
Limits
The study is entirely in vitro, using a single immortalized endothelial cell line (EA.hy926) rather than primary cells or an in vivo animal model. Physiological bioavailability, digestive stability, and in vivo vascular delivery of B-ELNs were not assessed. Specific numerical data for viability and ROS inhibition were omitted from the abstract.
Cited by
- supports Plant-derived exosomes can modify human gene expression.